Skip to main content
Log in

Adjusting for health-related QOL does not appear to substantially affect cost per life year (LY) ratios for most cancer studies

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Greenberg D, Cohen JT, Fang C, Neumann PJ.How Much Does Adjusting For Health-Related Quality Of Life Matter In Cost-Effectiveness Analysis? A Comparison Of Cost/Life Year And Cost/Qaly Estimates For Cancer Interventions. 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: abstr. CN1, 24 Oct 2009. Available from: URL: http://www.ispor.org/Events/Index.aspx?eventId=30

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adjusting for health-related QOL does not appear to substantially affect cost per life year (LY) ratios for most cancer studies. Pharmacoecon. Outcomes News 591, 6 (2009). https://doi.org/10.2165/00151234-200905910-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905910-00009

Keywords

Navigation